Identity
- Trade Name
- Nerivio Infinity FDA UDI
- Generic Name
- Craniofacial analgesia electrical stimulator FDA UDI
- Device Name
- Nerivio Infinity is a wireless remote electrical neuromodulation (REN) device for the acute and/or preventive treatment of migraine with or without aura in patients 8 years of age or older. This prescription device is self-applied to the upper arm and should be used in the home environment at the onset of migraine headache or aura. or every other day for preventive treatment. Nerivio Infinity utilizes an endogenous descending analgesic mechanism in which pain in one part of the body inhibits pain in multiple remote body regions (Conditioned Pain Modulation [CPM]). Nerivio Infinity is a wireless wearable battery-operated device controlled by a mobile software application. The battery is rechargeable, and the electronic unit can be used up to 3 years. The Nerivio Infinity Refill is a disposable and replaceable unit. The refill unit is sufficient for up to 18 treatments of 45 minutes each. The application has a graphical user interface (GUI) that includes graphical controls that the user can select using a touch screen. This application activates the stimulation, controls the stimulation intensity, monitors the treatment duration, and pauses and terminates the stimulation. The application also provides notifications and indications on the connection state and the remaining number of treatments. The Nerivio Infinity package under this UDI contains 3 refill units. FDA UDI
- Model / Reference
- FGD000100 FDA UDI
- Description
- Nerivio Infinity is a wireless remote electrical neuromodulation (REN) device for the acute and/or preventive treatment of migraine with or without aura in patients 8 years of age or older. This prescription device is self-applied to the upper arm and should be used in the home environment at the onset of migraine headache or aura. or every other day for preventive treatment. Nerivio Infinity utilizes an endogenous descending analgesic mechanism in which pain in one part of the body inhibits pain in multiple remote body regions (Conditioned Pain Modulation [CPM]). Nerivio Infinity is a wireless wearable battery-operated device controlled by a mobile software application. The battery is rechargeable, and the electronic unit can be used up to 3 years. The Nerivio Infinity Refill is a disposable and replaceable unit. The refill unit is sufficient for up to 18 treatments of 45 minutes each. The application has a graphical user interface (GUI) that includes graphical controls that the user can select using a touch screen. This application activates the stimulation, controls the stimulation intensity, monitors the treatment duration, and pauses and terminates the stimulation. The application also provides notifications and indications on the connection state and the remaining number of treatments. The Nerivio Infinity package under this UDI contains 3 refill units. FDA UDI
Identifiers
- Catalog Number
- FGD000100 FDA UDI
- Primary DI / UDI-DI
- 07290017578101 FDA UDI
- FDA Product Code
- QGT FDA UDI
- GMDN Term
- Craniofacial analgesia electrical stimulator FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 882.5899 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
No
FDA UDI
Serial Number
Yes
FDA UDI
Expiration Date
No
FDA UDI
Manufacturing Date
Yes
FDA UDI
MR Unsafe FDA UDI
Category: Craniofacial analgesia electrical stimulator
Nerivio Infinity by Theranica Bio-Electronics, Ltd. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Craniofacial analgesia electrical stimulator.
- ClearUP Sinus Relief Pain — Tivic Health Systems, Inc. · Class II
- ClearUP Sinus Pain Relief — Tivic Health Systems, Inc. · Class II
- Cefaly® — Cefaly Technology SPRL · Class II
- HeadaTerm — Wat Medical Technology, Inc. · Class II
- Cefaly® — Cefaly Technology SPRL · Class II
- Cefaly® — Cefaly Technology SPRL · Class II
- ELEXIR — Nu Eyne Co., Ltd. · Class II
- HeadaTerm — Wat Medical Technology, Inc. · Class II
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Theranica Bio-Electronics, Ltd.
Sources (1)
- FDA UDI 729df0be-7bc6-42ca-b296-2eb0049a785d 36 fields · synced May 30, 2026